Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $782.15 billion, total revenue of $166.47 billion and a weighted average PE ratio of 52.26.
Market Cap
782.15B
Revenue
166.47B
Profits
14.97B
PE Ratio
52.26
Profit Margin
8.99%
Dividend Yield
0.19%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 217.70B | -0.69% | 739,278 | 43.74B |
| 2 | DHR | Danaher Corporation | 161.70B | -0.76% | 1,270,206 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 54.02B | -0.85% | 276,156 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 38.58B | -1.13% | 949,936 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.39B | -1.00% | 502,217 | 15.90B |
| 6 | NTRA | Natera, Inc. | 31.69B | -0.39% | 617,778 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.48B | -1.42% | 64,206 | 3.94B |
| 8 | WAT | Waters Corporation | 22.61B | -1.08% | 217,588 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 20.80B | -0.87% | 381,692 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 20.04B | -1.20% | 777,369 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.30B | -1.12% | 645,304 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.27B | -0.33% | 1,469,061 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.82B | -1.27% | 163,829 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.91B | -0.43% | 309,633 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.16B | 1.53% | 1,026,208 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 10.97B | -0.70% | 636,163 | 2.81B |
| 17 | CRL | Charles River Laboratories International, Inc. | 9.82B | -1.24% | 312,022 | 4.02B |
| 18 | QGEN | Qiagen N.V. | 9.75B | -0.77% | 662,410 | 2.07B |
| 19 | RDNT | RadNet, Inc. | 5.51B | -0.20% | 725,413 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.01B | -0.62% | 1,577,034 | 1.15B |
| 21 | WGS | GeneDx Holdings Corp. | 3.76B | 1.61% | 369,933 | 402.19M |
| 22 | BLLN | BillionToOne, Inc. | 3.75B | -3.82% | 331,448 | 254.14M |
| 23 | GRAL | GRAIL, Inc. | 3.34B | 0.34% | 762,522 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.33B | -0.43% | 548,616 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.94B | -1.34% | 849,753 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.52B | -3.84% | 1,331,148 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.52B | -0.85% | 1,763,666 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.14B | -1.04% | 330,377 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 968.99M | -1.21% | 371,754 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 967.30M | -3.08% | 4,948,843 | 642.07M |
| 31 | FLGT | Fulgent Genetics, Inc. | 812.07M | -0.83% | 173,493 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 706.88M | -0.13% | 559,854 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 573.26M | -0.32% | 669,987 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 265.05M | 0.06% | 83,423 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 216.95M | -2.30% | 11,672 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 214.98M | 7.14% | 66,707 | 4.40M |
| 37 | MDXH | MDxHealth SA | 176.71M | 1.71% | 144,043 | 103.07M |
| 38 | XGN | Exagen Inc. | 137.79M | 1.50% | 1,067,406 | 63.60M |
| 39 | FONR | FONAR Corporation | 121.59M | -0.22% | 201,435 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 54.10M | 1.19% | 29,846 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 40.26M | -1.84% | 5,679 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 19.32M | 2.85% | 483,501 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 9.61M | -3.45% | 168,979 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 9.48M | -2.99% | 98,453 | - |
| 45 | ADVB | Advanced Biomed Inc. | 6.31M | -13.82% | 272,357 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 5.30M | -4.07% | 138,387 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.28M | -4.83% | 21,463 | - |
| 48 | XWEL | XWELL, Inc. | 2.66M | -7.84% | 136,116 | 29.52M |
| 49 | ISPC | iSpecimen Inc. | 2.54M | -12.07% | 21,534,538 | 3.35M |
| 50 | PRPH | ProPhase Labs, Inc. | 2.07M | -1.28% | 532,280 | 5.06M |